In 2011, the U.S. Food and Drug Administration issued a patient safety communication regarding the use of synthetic mesh for the surgical repair of stress urinary incontinence (SUI) and pelvic organ prolapse and held a hearing on the topic. The AUA, along with the Society for Female Urology and Urodynamics (SUFU) and the American Urogynecologic Society (AUGS) and other groups, provided testimony at the hearing. Additionally, the AUA developed position statements on the use of mesh for SUI and pelvic organ prolapse.
“FDA Panel Recommends Reclassification of Surgical Mesh”AUA Health Policy Brief, November 2011
“FDA Issues New Safety Communication about the Use of Mesh to Treat Pelvic Organ Prolapse”AUA Health Policy Brief, August 2011
Alert to AUA MembershipJuly 2011